Fresenius Kabi AG

In News

Fresenius Kabi Expands Operating Room Portfolio with New Simplist® Prefilled Syringes - Business Wire

Business Wire - Dec 02, 2025

Fresenius Kabi introduces generic Dalvance - Drug Store News

Drug Store News - Dec 01, 2025

Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only) - Yahoo Finance

Yahoo Finance - Nov 24, 2025

Update on Alert: Infusion Pump Issue from Fresenius Kabi USA - fda.gov

fda.gov - Mar 05, 2025

Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient® - Yahoo Finance

Yahoo Finance - Sep 25, 2025

‘Our Commitment Is Serious’: Fresenius Kabi’s CEO Pierluigi Antonelli On Biosimilars And Beyond - Citeline News & Insights

Citeline News & Insights - Mar 24, 2025

Fresenius Kabi, Formycon Launch Otulfi in U.S. - Contract Pharma

Contract Pharma - Mar 20, 2025

Ringer's Solution Market to Witness Massive Growth by 2032 | - openPR.com

openPR.com - Nov 24, 2025

Fresenius Kabi to announce the commercial launch of Otulfi™*, an approved Ustekinumab Biosimilar in Canada - Newswire Canada

Newswire Canada - May 27, 2025

Fresenius Kabi Introduces Epinephrine Injection, USP, in 30 mg per 30 mL Multi-Dose Vials - Business Wire

Business Wire - May 20, 2025

Fresenius Kabi releases epinephrine injection in new dosage strength - Drug Store News

Drug Store News - May 28, 2025

Kabi Lines Up Denosumab Biosimilar Launch As FDA Says Yes To Filings - Citeline News & Insights

Citeline News & Insights - Mar 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment